MDx Firm Multiplicom Raises $7.3M | GenomeWeb

NEW YORK (GenomeWeb News) – Multiplicom has raised €5.5 million ($7.3 million) to support further development of its molecular diagnostic tests and expansion of its business.

Flemish investment firm PMV, RMM (Rudi Mariën) and Qbic ARKIV Fund were new investors in the round. Existing investors including Belgian venture capital firm Gimv, Gimv-managed Biotechfonds Vlaanderen, and life science research institute VIB continue to support Multiplicom, it said, adding VIB will make an investment in kind.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.